Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v3-EN | Version v2-FR | |
|---|---|---|
| Language | English | French |
| Date Updated | 2022-10-05 | 2022-10-03 |
| Drug Identification Number | 02139510 | 02139510 |
| Brand name | SODIUM CHLORIDE INJECTION, USP | SODIUM CHLORIDE INJECTION, USP |
| Common or Proper name | SODIUM CHLORIDE INJECTION, USP | SODIUM CHLORIDE INJECTION, USP |
| Company Name | FRESENIUS KABI CANADA LTD | FRESENIUS KABI CANADA LTD |
| Ingredients | SODIUM CHLORIDE | SODIUM CHLORIDE |
| Strength(s) | 234MG | 234MG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS | INTRAVENOUS INTRAVENOUS |
| Packaging size | 100mL | 100mL |
| ATC code | B05XA | B05XA |
| ATC description | I.V. SOLUTION ADDITIVES | I.V. SOLUTION ADDITIVES |
| Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
| Anticipated start date | 2022-10-04 | 2022-10-04 |
| Actual start date | 2022-10-04 | 2022-10-04 |
| Estimated end date | Unknown | Unknown |
| Actual end date | ||
| Shortage status | Actual shortage | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | Fresenius Kabi Canada is pleased to advise that our Sodium Chloride Injection, USP 4mEq/mL Maxivial® 100 mL will be available at Ontario distribution centres by October 4, 2022 and at all other distribution centres by October 6, 2022. Once available, this product will be placed on allocation. Contract customers will be allocated 100% of historical monthly demand. | Fresenius Kabi Canada is pleased to advise that our Sodium Chloride Injection, USP 4mEq/mL Maxivial® 100 mL will be available at Ontario distribution centres by October 4, 2022 and at all other distribution centres by October 6, 2022. Once available, this product will be placed on allocation. Contract customers will be allocated 100% of historical monthly demand. |
| Health Canada comments |